The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Optimal Use of Diabetes Devices: Clinician Perspectives on Barriers and Adherence to Device Use
Open accessAbstract
BACKGROUND: Insulin pumps and continuous glucose monitors (CGM) can improve glycemic control for individuals with type 1 diabetes (T1D). Device uptake rates continue to show room for improvement, and consistent adherence is needed to achieve better outcomes. Diabetes health care providers have important roles to play in promoting device use and adherence. METHODS: We surveyed 209 clinicians who treat people with type 1 diabetes to examine perceptions of barriers to device uptake, attitudes toward diabetes technology, and resources needed for clinicians to improve device uptake. We compared findings with our survey of adults with T1D. RESULTS: Younger clinicians treated more patients using insulin pumps ( r = -.26, P < .001) and CGM ( r = -.14, P = .02), and had more positive attitudes about diabetes technology ( r = -.23, P = .001). The most frequently endorsed modifiable barriers were perceptions that patients dislike having the device on their body (73% pump; 63% CGM), dislike the alarms (61% CGM), and do not understand what to do with device information or features (40% pump; 46% CGM). Clinicians wanted lower cost and better insurance coverage for their patients, and they recommended counseling and education to help address barriers and improve adherence to devices. CONCLUSION: Clinicians perceive many barriers to their patients initiating and adhering to diabetes devices. Findings highlight opportunities for intervention to improve clinician-patient communication around device barriers to help address them.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For people with insulin-requiring diabetes, dosing instructions may be complex and confusing (3-6).”
From Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis (2025) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As injection therapy is used by more than 80% of people with insulin-requiring diabetes, there is a clear need for intuitive, integrated systems to help multiple daily injection (MDI) patients interpret CGM data into actionable management steps to reduce the burden of demanding self-care directives and support telemedicine (3, 6, 10-13).”
From Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis (2025) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“While recent guidelines call for continuous glucose monitoring (CGM) use for all who require insulin, regardless of diabetes type (7), there is also evidence that patients may not know how to interpret what to do with the CGM data (6, 8, 9).”
From Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis (2025) · cites this paper as [6]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As injection therapy is used by more than 80% of people with insulin-requiring diabetes, there is a clear need for intuitive, integrated systems to help multiple daily injection (MDI) patients interpret CGM data into actionable management steps to reduce the burden of demanding self-care directives and support telemedicine (3, 6, 10-13).”
From Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis (2025) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Miller, K. M., Foster, N. C., Beck, R. W., Bergenstal, R. M., DuBose, S. N., DiMeglio, L. A., Maahs, D. M., & Tamborlane, W. V. (2015) · Diabetes Care · doi:10.2337/dc15-0078 · Cited by 1,254
Klonoff, D. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1231 · Cited by 725
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry
Wong, J. C., Foster, N. C., Maahs, D. M., Raghinaru, D., Bergenstal, R. M., Ahmann, A. J., Peters, A. L., Bode, B. W., Aleppo, G., Hirsch, I. B., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0303 · Cited by 318
Use of Insulin Pump Therapy in the Pediatric Age-Group
Phillip, M., Battelino, T., Rodriguez, H., Danne, T., KAUFMAN, F. R., & participants, F. T. C. F. (2007) · Diabetes Care · doi:10.2337/dc07-9922 · Cited by 311
Sensor-Augmented Insulin Pump Therapy: Results of the First Randomized Treat-to-Target Study
Hirsch, I. B., Abelseth, J. M., Bode, B. W., Fischer, J. S., KAUFMAN, F. R., Mastrototaro, J. J., Parkin, C. G., Wolpert, H. A., & Buckingham, B. A. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0068 · Cited by 297
Tanenbaum, M. L., Hanes, S. J., Miller, K. M., Naranjo, D., Bensen, R., & Hood, K. K. (2017) · Diabetes Care · doi:10.2337/dc16-1536 · Cited by 296
Factors Predictive of Use and of Benefit From Continuous Glucose Monitoring in Type 1 Diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0889 · Cited by 250
Pickup, J. C., Holloway, M., & Samsi, K. (2014) · Diabetes Care · doi:10.2337/dc14-1855 · Cited by 203
Chase, H. P., Beck, R. W., Xing, D., Tamborlane, W. V., Coffey, J., Fox, L. A., Ives, B., Keady, J., Kollman, C., Laffel, L. M., et al. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0021 · Cited by 142
Research works printed but not linked: 2
- 10.1056/NEJMoa0805017 · DOI · Paper page
- Borges U, J Diabetes Sci Technol
Cited by
Sorted by citations
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288
Continuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology
Galindo, R. J., & Aleppo, G. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108502 · Cited by 144
Messer, L. H., Tanenbaum, M. L., Cook, P. F., Wong, J. J., Hanes, S. J., Driscoll, K. A., & Hood, K. K. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0509 · Cited by 131
Braune, K., Lal, R. A., Petruželková, L., Scheiner, G., Winterdijk, P., Schmidt, S., Raimond, L., Hood, K. K., Riddell, M. C., Skinner, T. C., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00267-9 · Cited by 130
Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes
Lal, R., Ekhlaspour, L., Hood, K. K., & Buckingham, B. A. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00174 · Cited by 102
Addala, A., Maahs, D. M., Scheinker, D., Chertow, S., Leverenz, B., & Prahalad, P. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13082 · Cited by 83
Kanbour, S., Jones, M., Abusamaan, M. S., NASS, C. M., Everett, E. M., Wolf, R. M., Sidhaye, A. R., & Mathioudakis, N. N. (2022) · Diabetes Care · doi:10.2337/dc22-1055 · Cited by 88
Lawton, J., Kimbell, B., Rankin, D., Ashcroft, N. L., Varghese, L., Allen, J. M., Boughton, C. K., Campbell, F., Randell, T. L., Besser, R. E. J., et al. (2020) · Diabetic Medicine · doi:10.1111/dme.14252 · Cited by 54
Improving patient self-care using diabetes technologies
Alcántara-Aragón, V. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818824215 · Cited by 53
Monitoring of Pediatric Type 1 Diabetes
Marks, B. E., & Wolfsdorf, J. I. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00128 · Cited by 55
Tanenbaum, M., Adams, R., Lanning, M. S., Hanes, S., Agustin, B. I., Naranjo, D., & Hood, K. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818786486 · Cited by 43
Barriers to Uptake of Insulin Technologies and Novel Solutions
PAULEY, M. E., Berget, C., Messer, L. H., & Forlenza, G. P. (2021) · Medical Devices Evidence and Research · doi:10.2147/mder.s312858 · Cited by 51
A critical review and analysis of ethical issues associated with the artificial pancreas
Quintal, A., Messier, V., RABASA-LHORET, R. P. R., & Racine, É. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.04.003 · Cited by 48
Psychosocial aspects of diabetes technology
Kubiak, T., Priesterroth, L., & Barnard-Kelly, K. D. (2020) · Diabetic Medicine · doi:10.1111/dme.14234 · Cited by 44
Braune, K., Boß, K., Schmidt-Herzel, J., Gajewska, K. A., Thieffry, A., Schulze, L., Posern, B., & Raile, K. (2020) · JMIR mhealth and uhealth · doi:10.2196/24374 · Cited by 48
Forlenza, G. P., Messer, L. H., Berget, C., Wadwa, R. P., & Driscoll, K. A. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1078-1 · Cited by 43
Barriers to continuous glucose monitoring in people with type 1 diabetes: clinician perspectives
Lanning, M. S., Tanenbaum, M. L., Wong, J. J., & Hood, K. K. (2020) · Diabetes Spectrum · doi:10.2337/ds19-0039 · Cited by 40
Barriers and Facilitators to Diabetes Device Adoption for People with Type 1 Diabetes
Tanenbaum, M. L., & COMMISSARIAT, P. V. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01469-w · Cited by 47
Prahalad, P., Addala, A., Buckingham, B. A., Wilson, D. M., & Maahs, D. M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0204 · Cited by 40
Intermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGM
Ziegler, R., Heinemann, L., Freckmann, G., Schnell, O., Hinzmann, R., & Kulzer, B. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820905577 · Cited by 40
Addala, A., Suttiratana, S. C., Wong, J. J., Lanning, M. S., Barnard, K. D., Weissberg-Benchell, J. A., Laffel, L. M., Hood, K. K., & Naranjo, D. M. (2021) · Diabetic Medicine · doi:10.1111/dme.14575 · Cited by 39
Bisio, A., Anderson, S. M., Norlander, L., O’Malley, G., Robic, J., OGYAADU, S. J., Hsu, L. J., Levister, C. M., Ekhlaspour, L., Lam, D. W.-H., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0838 · Cited by 36
Barriers to Type 1 Diabetes Adherence in Adolescents
Azar, S., Jaoude, N. M. A., Kędzia, A. W., & Niechciał, E. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195669 · Cited by 47
Personal Versus Professional Continuous Glucose Monitoring: When to Use Which on Whom
Longo, R. R., & Sperling, S. B. (2019) · Diabetes Spectrum · doi:10.2337/ds18-0093 · Cited by 30
Datye, K. A., Tilden, D. R., Parmar, A. M., Goethals, E. R., & Jaser, S. S. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01389-1 · Cited by 32
Elian, V., Popovici, V., Ozon, E.-A., Musuc, A. M., Fița, A. C., Rusu, E., Radulian, G., & Lupuliasa, D. (2023) · Life · doi:10.3390/life13081663 · Cited by 34
Bergloff, A., Stratton, E., & Early, K. B. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0161 · Cited by 28
Santos, T. J. D., Dave, C., MacLeish, S. A., & Wood, J. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002537 · Cited by 28
Been, R. A., Lameijer, A., Gans, R. O. B., van Beek, A. P., Kingsnorth, A. P., Choudhary, P., & van Dijk, P. R. (2024) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188241236289 · Cited by 27
Tanenbaum, M. L., Messer, L. H., Wu, C., Basina, M., Buckingham, B. A., Hessler, D., Mulvaney, S. A., Maahs, D. M., & Hood, K. K. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109048 · Cited by 27
Conway, B. N., Snell‐Bergeon, J. K., Honda-Kohmo, K., Peddi, A. K., Isa, S. B., Sulong, S., Sibomana, L., Gonzalez, A. G., Song, J., Lomax, K., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae210 · Cited by 29
Manning, M. L., Singh, H., STONER, K. C., & HABIF, S. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819897976 · Cited by 24
Kompala, T., Wong, J. C., & Neinstein, A. B. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221088267 · Cited by 21
Aleppo, G., DeSalvo, D. J., Lauand, F., Huyett, L. M., Chang, A., Vienneau, T., & Ly, T. T. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01366-9 · Cited by 19
Bisno, D. I., Reid, M. W., Pyatak, E. A., Garcia, J. F., Salcedo-Rodriguez, E., Sanchez, A. T., Fox, D. S., Hiyari, S., Fogel, J. L., Marshall, I., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0199 · Cited by 21
Farrington, C., Murphy, H. R., & Hovorka, R. (2020) · Diabetic Medicine · doi:10.1111/dme.14235 · Cited by 18
Who Should Access Closed-Loop Technology? A Qualitative Study of Clinician Attitudes in England
Farrington, C., Hovorka, R., & Murphy, H. R. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0380 · Cited by 18
Messer, L. H., Berget, C., Ernst, A., Towers, L., Slover, R. H., & Forlenza, G. P. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13183 · Cited by 15
Zhang, D., Huang, J., Zhang, Y. H., Wei, Z., Long, T., Guo, X., & Li, M. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112907 · Cited by 15
CHANDRAN, S. R., Vigersky, R. A., Thomas, A., Lim, L., Ratnasingam, J., Tan, A. T. B., & Gardner, D. S.-L. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0277 · Cited by 14
Lingen, K., Maahs, D. M., Bellini, N. J., & Isaacs, D. M. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0440 · Cited by 13
Brixner, D. I., Edelman, S. V., Sieradzan, R., & Gavin, J. R. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01598-3 · Cited by 14
Song, C., Booth, G. L., Perkins, B. A., & Weisman, A. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002371 · Cited by 12
DuBord, A. Y., Paolillo, E. W., & Staffaroni, A. M. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231171399 · Cited by 12
May, S. G., Huber, C., Roach, M., Shafrin, J. T., Aubry, W. M., Lakdawalla, D. N., Kane, J. M., & Forma, F. M. (2021) · Journal of Medical Internet Research · doi:10.2196/18119 · Cited by 12
DiabetesWise : An innovative approach to promoting diabetes device awareness
Wong, J. J., Addala, A., Hanes, S. J., Krugman, S., Naranjo, D. M., Nelmes, S., Rose, K. J., Tanenbaum, M. L., & Hood, K. K. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13401 · Cited by 11
Nozha, O. M. A., Alshareef, E. K., Aljawi, A. F., Alhabib, E., AlMahweeti, R. S., Aljuhani, S. A., Alamri, S. A., & Alahmadi, O. S. (2022) · Cureus · doi:10.7759/cureus.25038 · Cited by 11
Molfetta, S. D., Rossi, A., Assaloni, R., Cherubini, V., Consoli, A., Bartolo, P. D., Guardasole, V., Laurenzi, A., Lombardo, F., Maffeis, C., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109867 · Cited by 13
Availability and Accessibility of Diabetes-Related Technologies in IDF-MENA Region
Ghafoor, E., Masood, S. N., Belkhadir, J., Sultan, M. T. H., Sandid, M., Baqai, S. M., & Shegem, N. (2022) · Journal of Diabetology · doi:10.4103/jod.jod_117_22 · Cited by 9
Glucose Response to Fast- and Long-Acting Insulin in People with Type 2 Diabetes
Engell, S. E., Aradóttir, T. B., Bengtsson, H. L., Ekelund, M., & Jørgensen, J. B. (2021) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2021.10.305 · Cited by 8
Improving the Patient Experience With Longer Wear Infusion Sets Symposium Report
Nguyen, K. T., Xu, N. Y., Buckingham, B. A., CHATTARAJ, S., Cohen, O., Heinemann, L., Pickup, J. C., Svensson, J., Vigersky, R. A., Wong, J. C., et al. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221078884 · Cited by 9
Pediatric Smart Insulin Pen Use: The Next Best Thing
Ilkowitz, J. T., Wissing, V., & GALLAGHER, M. P. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211041362 · Cited by 7
Hankosky, E. R., Katz, M. L., Fan, L., Liu, D., Chinthammit, C., Brnabic, A. J. M., & Eby, E. L. (2023) · Current Medical Research and Opinion · doi:10.1080/03007995.2023.2205795 · Cited by 7
Decisions in the Psychology of Glucose Monitoring
Reach, G. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819854109 · Cited by 7
Simulation Platform Development for Diabetes and Technology Self-Management
Faulds, E. R., Rayo, M. F., Lewis, C. J., Noble, C. W., Gifford, R. C., Happ, M. B., Joyce, L., & Dungan, K. M. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211029303 · Cited by 7
Owusu, B., Bivins, B. L., Juste, J., Francis, L., Itambo, J., Akomah, J., Yorukoglu, N., Gbaba, S., Hinneh, T. K., Ajibewa, T. A., et al. (2024) · Journal of Advanced Nursing · doi:10.1111/jan.16277 · Cited by 6
Dicks, J. H., McCann, L. J., Tolley, A., Barrell, A. M., Johnson, L., Kuhn, I. L., & Ford, J. A. (2025) · Pediatric Diabetes · doi:10.1155/pedi/8875203 · Cited by 10
Straton, E., Inverso, H., Moore, H. R., Anifowoshe, K., Washington, K., Streisand, R. M., Datye, K. A., & Jaser, S. S. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231186428 · Cited by 7
Hilliard, M. E., COMMISSARIAT, P. V., Kanapka, L. G., Laffel, L. M., Levy, W. L., Harrington, K. R., Anderson, B. J., Miller, K. M., & DiMeglio, L. A. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13349 · Cited by 6
A Qualitative Analysis of Provider‐Level Barriers to Prescribing Diabetes Technology
Maizel, J. L., Walker, A. F., Walls, A., Pasquel, F. J., Haller, M. J., & Bruggeman, B. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/8873848 · Cited by 7
Hall, T. L., Dickinson, L. M., Warman, M. K., Oser, T. K., & Oser, S. M. (2024) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000001060 · Cited by 7
Mizokami‐Stout, K., Thompson, H. M., Hurren, K. M., LEONE, V. A., Piatt, G., Lee, J. M., Pop‐Busui, R., & DeJonckheere, M. J. (2023) · JMIR Diabetes · doi:10.2196/45241 · Cited by 5
Holt, E., Nguyen, H., Bispham, J. A., Liu, J., CHAPMAN, K. S. M., & Grady, M. (2023) · Clinical Diabetes · doi:10.2337/cd23-0005 · Cited by 5
Insulin pump therapy: education and its goals
Štechová, K. (2019) · Vnitřní lékařství · doi:10.36290/vnl.2019.042 · Cited by 5
Fantasia, K. L., Modzelewski, K. L., & Steenkamp, D. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818823538 · Cited by 5
Yap, P. X. C., Koh, L., Gallagher, P., & Lum, Z. K. (2021) · Journal of Diabetology · doi:10.4103/jod.jod_49_21 · Cited by 4
Socioeconomic factors: access to and use of diabetes technologies
Barry, S., Wagner, D. V., Stoeckel, M., & Harris, M. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817485-2.00011-0 · Cited by 4
Barriers to access to insulin pumps in Chile: A qualitative study of a high-cost technology
Cabieses, B., V, Alexandra Obach, K., Madrid, P., & Paredes-Fernández, D. (2025) · Health Policy and Technology · doi:10.1016/j.hlpt.2025.100992 · Cited by 3
Esposito, K., Bolla, A. M., Costantino, F., Delvecchio, M., Molinari, C., Negri, C., Petrizzo, M., & Bosi, E. (2021) · AboutOpen · doi:10.33393/ao.2021.2266 · Cited by 3
The Elderly Lag Behind in the Use of Intermittent Scanning Continuous Glucose Monitoring
Been, R. A., van Beek, A. P., Gans, R. O. B., & van Dijk, P. R. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221126691 · Cited by 3
Adolescent ambivalence about diabetes technology—The Janus faces of automated care
Cameron, F. J., Arnold, M., & Gregory, J. W. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13423 · Cited by 3
RAIMOND, L. H., O’Donnell, S., Bøggild-Damkvist, T., Filges, T., & Lomborg, K. E. (2022) · Chronic Illness · doi:10.1177/17423953221142341 · Cited by 3
Association of Continuous Glucose Monitor Receipt and Diabetes Care Provider Type
Gaulke, A., Giordano, J., & Grossman, D. S. (2023) · Medical Care · doi:10.1097/mlr.0000000000001917 · Cited by 3
Technological Innovations in Type 1 Diabetes Mellitus Management: A Narrative Review
Gunatilake, S. S. C. (2024) · Sri Lanka Journal of Diabetes Endocrinology and Metabolism · doi:10.4038/sjdem.v15i1.7534 · Cited by 3
Mayberry, L. S., Nelson, L. A., Bergner, E. M., Raymond, J. K., Tanenbaum, M. L., Jaser, S. S., Wiebe, D. J., Allen, N. A., Berg, C. A., Naranjo, D. M., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241268560 · Cited by 3
McCarthy, G. (2018) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17067899 · Cited by 3
Similar Perceptions on Continuous Glucose Monitor Use amongst Youth with Type 1 and Type 2 Diabetes
Phu, A., Lin, T., Manfredo, J. A., Brown, E. A., & Wolf, R. M. (2023) · Pediatric Diabetes · doi:10.1155/2023/1979635 · Cited by 2
Aouchiche, K., Bernoux, D., Baechler-Sadoul, E., Haine, E., Joubert, F., Epstein, S., Galon-Faure, N., Dalla‐Vale, F., Combe, J.-C., Samper, M., et al. (2024) · Archives de Pédiatrie · doi:10.1016/j.arcped.2024.09.005 · Cited by 2
Quo vadis, structured diabetes education? Between digitalization and technologization.
Ehrmann, D., & Hermanns, N. (2022) · Patient Education and Counseling · doi:10.1016/j.pec.2022.03.010 · Cited by 1
Barnard-Kelly, K. D., Thienel, F., Mader, J. K., Oliver, N. S., Franek, E., Vesper, I., DAGENBACH, N., Vogt, G., ETTER, T. J., & Künsting, T. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241234055 · Cited by 2
Kruger, D. F., Isaacs, D. M., Hughes, L., Miller, E. M., & Bailey, T. S. (2024) · Postgraduate Medicine · doi:10.1080/00325481.2024.2331417 · Cited by 2
Managing Diabetes in the Digital Age
Dugan, J. A., Ahmed, S., Vincent, M., Perry, R., & Young, C. F. (2020) · Physician Assistant Clinics · doi:10.1016/j.cpha.2019.12.003 · Cited by 2
Hoogendoorn, C. J., Ehrmann, D., Crespo-Ramos, G., Asman, A. G., & Gonzalez, J. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817485-2.00006-7 · Cited by 2
Düzalan, Ö. B., & İnkaya, B. V. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.01.001 · Cited by 2
Muriel, R. A. S. (2022) · Gredos (University of Salamanca) · doi:10.14201/gredos.149564 · Cited by 2
Tillman, J. B., Beck, R. W., Polonsky, W. H., Calhoun, P., Mouse, T., Bailey, R., Jacoby, J., Nandan, R., Sheikh, F. N., & Malone, J. K. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae778 · Cited by 1
Development and evaluation of the Flourish Diabetes Programme
Kruger, S., Deacon, E., van Rensburg, E., & Segal, D. (2025) · Health SA Gesondheid · doi:10.4102/hsag.v30i0.2923 · Cited by 1
Timing of insulin pump initiation among individuals with type 1 diabetes in Ontario, Canada
Zhu, X., Lipscombe, L. L., Shulman, R. M., Lovblom, L. E., Everett, K., & Weisman, A. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70514 · Cited by 1
Parimi, N., Wu, C., Ziglar, J., Brown, E. A., Sidhaye, A. R., Mathioudakis, N. N., & Wolf, R. M. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968261426387 · Cited by 1
Zhu, H., Du, L., Liu, X., & Richardson, A. G. (2026) · Annals of Biomedical Engineering · doi:10.1007/s10439-026-04297-1 · Cited by 1
New Paradigm of Personalized Glycemic Control Using Glucose Temporal Density Histograms
Trahtemberg, U., Hallas, T., Segman, Y., Sheiman, E., Shasha, M., Nissim, K., & Segman, Y. J. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818821423 · Cited by 1
Messina, R., Indelicato, L., Iommi, M., Trombetta, M., Roos, T., Hermanns, N., Sipio, A. D., Fantini, M. P., & Calvo, V. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02046-7 · Cited by 1
Bahreman, N. T., Dietrich, M. S., Jaser, S. S., Akard, T. F., & Mulvaney, S. A. (2023) · Pediatric Diabetes · doi:10.1155/2023/5597133 · Cited by 1
An Ethical Perspective on the Social Value of Cell-Based Technologies in Type 1 Diabetes
de Jongh, D., & Bunnik, E. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-41943-0_19 · Cited by 1
de Jongh, D., Bunnik, E. M., Özcan, B., Zietse, R., & Massey, E. K. (2024) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2024.100372 · Cited by 1
Huynh, L., Booth, M., & Osuagwu, U. L. (2024) · Nutrients · doi:10.3390/nu16213779 · Cited by 1
Assessing a Personalized, Hybrid, and Generic Approach for Glucose Prediction in Type 1 Diabetes
Bosoni, P., Jensen, M. H., Bellazzi, R., & Cichosz, S. L. (2024) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm62325.2024.10822179 · Cited by 2
Cui, Y., Stanger, C., & Prioleau, T. (2025) · Scientific Reports · doi:10.1038/s41598-025-98276-6 · Cited by 1
Addala, A., Howard, K. R., HOSSEINIPOUR, Y. J., & Ekhlaspour, L. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241285045 · Cited by 1
Technology Advancement: Hybrid Closed-Loop Insulin Pump
Lausch, M. J. (2018) · AADE in Practice · doi:10.1177/2325160318789152
Metadata
- Authors
- Tanenbaum, M. L., Adams, R. N., Hanes, S. J., Barley, R. C., Miller, K. M., Mulvaney, S. A., & Hood, K. K.
- Affiliations
- Stanford Medicine (US)
- Jaeb Center for Health Research (US)
- Vanderbilt University (US)
- Corresponding author
- Hood, Korey K.
- ORCID
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2017-01-10
- Volume
- 11
- Issue
- 3
- Pages
- 484-492
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC5505431
- OpenAlex
- W2572387108
- Cited by
- 117
- References
- 30
- Citations by year
- 2026: 12 · 2025: 8 · 2024: 21 · 2023: 15 · 2022: 14 · 2021: 16 · 2020: 15 · 2019: 9 · 2018: 7
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Leona M. and Harry B. Helmsley Charitable Trust
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Keywords
- type 1 diabetes, insulin pump, continuous glucose monitors, diabetes technology adoption, device adherence, clinician attitudes, clinician-patient communication, patient education, insurance coverage, device cost
- MeSH terms
- Adult, Diabetes Mellitus, Type 1, Female, Humans, Insulin Infusion Systems, Health Knowledge, Attitudes, Practice, Male, Middle Aged, Monitoring, Physiologic, Patient Compliance, Practice Patterns, Physicians', Surveys and Questionnaires
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review